knowledge -WSS

knowledge

author：entertainment 2025-09-27 10:02:50 - browse：927

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： STAT Madness 2024: Meet the contenders

Wikipedia

WSS

CDC panel: People 65 and older should get a Covid spring booster shot

Doctor of U.S. President Joe Biden says he is fit for duty

Change Healthcare cyberattack shows risk of industry consolidation

Neuroscience renaissance leads to new crop of psychiatric drugs

Medicare isn't yet testing food as medicine

Neuroscience renaissance leads to new crop of psychiatric drugs

leisure time

knowledge

Sign up for D.C. Diagnosis

knowledge

Moonlake's readout produced a cash windfall. Risks remain

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Beam, Prozac, "TechBio" and more

Hepatitis C has a cure — but many Americans still lack access to it

'Vaccine

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Using force crossed my mind when examining a defiant young patient

Continuity nursing helped my family in our darkest PICU moments

Study fuels hope CAR

entertainment

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Pfizer is about to make a big push in cancer. Will investors listen?

Elisabeth Bik tackles the widespread issue of research misconduct

Elisabeth Bik tackles the widespread issue of research misconduct

Elisabeth Bik tackles the widespread issue of research misconduct

NEJM study measures Covid brain fog, impact on IQ

knowledge

knowledge

Wikipedia

focus